Approvals/CIMA-AEMPS/DAPAGLIFLOZINA/METFORMINA AUROVITAS 5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

DAPAGLIFLOZINA/METFORMINA AUROVITAS 5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Aurovitas Spain, S.A.U.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: eb91924d1c907499
Drug Cima Aemps Name: DAPAGLIFLOZINA/METFORMINA AUROVITAS 5 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 91232
Holder Company Name: Aurovitas Spain, S.A.U.
Marketing Company Name: Aurovitas Spain, S.A.U.
Authorization Date: 2026-06-05
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 5 mg/850 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Aurovitas Spain, S.A.U.

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 5, 2026

Approval ID

eb91924d1c907499

Type

Standard